Sale!

Meloxicam Tablets 10mg (Mobic® / モービック錠10mg)

元の価格は JPY ¥2,500 でした。現在の価格は JPY ¥2,300 です。

Japanese non-steroidal anti-inflammatory and analgesic agent (Meloxicam 10mg). Oral tablet for once-daily administration after meals. 100 tablets [10 tablets (PTP) x 10]. Mfd. by Nippon Boehringer Ingelheim Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥2,300
10 - 19 12% JPY ¥2,200
20 + 18% JPY ¥2,050
SKU: MOB-10-TAB Category:

Description

Product Overview / 商品概要

Mobic Tablets 10mg (モービック錠10mg)
Generic: Meloxicam / メロキシカム
Therapeutic Category: Non-steroidal anti-inflammatory and analgesic agent / 非ステロイド性消炎・鎮痛剤
Manufactured by: Nippon Boehringer Ingelheim Co., Ltd. / 日本ベーリンガーインゲルハイム株式会社

Composition & Specification / 組成・規格

Active Ingredient: Meloxicam 10mg per tablet / 1錠中 メロキシカム 10mg
Additives: Sodium citrate hydrate, Lactose hydrate, Corn starch, Microcrystalline cellulose, Hydroxypropylcellulose, Crospovidone, Magnesium stearate / クエン酸ナトリウム水和物、乳糖水和物、トウモロコシデンプン、結晶セルロース、ヒドロキシプロピルセルロース、クロスポビドン、ステアリン酸マグネシウム
Appearance: Light yellow scored tablet, diameter approx. 8mm, thickness approx. 2.8mm, weight approx. 0.18g, identification code C10
外観: 淡黄色の割線入り錠剤、直径 約8mm、厚さ 約2.8mm、重さ 約0.18g、識別コード C10

Indications / 効能効果

EN: Anti-inflammatory and analgesic treatment for the following diseases and symptoms: Rheumatoid arthritis, Osteoarthritis, Low back pain, Periarthritis of the shoulder joint, Cervicobrachial syndrome
JA: 下記疾患並びに症状の消炎・鎮痛
関節リウマチ、変形性関節症、腰痛症、肩関節周囲炎、頸肩腕症候群

Dosage and Administration / 用法用量

EN: Usual adult dose: 10mg of meloxicam orally once daily after meals. Dose may be adjusted according to age and symptoms; maximum daily dose is 15mg.
JA: 通常、成人にはメロキシカムとして10mgを1日1回食後に経口投与する。なお、年齢、症状により適宜増減するが、1日最高用量は15mgとする。

Contraindications / 禁忌

EN: Patients with peptic ulcer; patients with serious blood disorders; patients with serious hepatic impairment; patients with serious renal impairment; patients with serious cardiac insufficiency; patients with serious hypertension; patients with history of hypersensitivity to components of this product, salicylates, or other NSAIDs; patients with aspirin-induced asthma or history thereof; pregnant women or women who may be pregnant
JA: 消化性潰瘍のある患者、重篤な血液の異常がある患者、重篤な肝機能障害のある患者、重篤な腎機能障害のある患者、重篤な心機能不全のある患者、重篤な高血圧症の患者、本剤の成分・サリチル酸塩・他のNSAIDsに対して過敏症の既往歴のある患者、アスピリン喘息またはその既往歴のある患者、妊婦または妊娠している可能性のある女性

Regulatory Information / 規制情報

Approval No.: 21600AMZ00547000
Sales Started: January 2005 / 2005年1月
Classification Code: 871149
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Meloxicam Tablets 10mg (Mobic® / モービック錠10mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Meloxicam Tablets 10mg (Mobic®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.